BioSystem Development Launches its AssayMAP(TM) MAb Titer Assay for Rapid, High-throughput Antibody Measurement in Bioprocess Samples  
12/9/2009 11:32:47 AM

MADISON, Wis.--(BUSINESS WIRE)--BioSystem Development, LLC., a privately held life science analytics company, announces the release of the AssayMAP MAb Titer Assay for measuring antibody product concentrations (or titers) in bioprocess samples.